Patent Expiry

Patent/Exclusivity Expiry: VIZAMYL

September 16, 2028

Company: GE HealthCare Technologies Inc. (GEHC)
Drug: VIZAMYL

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Patent/Exclusivity Expiry: VIZAMYL — GEHC Patent Expiry | BioSniper